➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Boehringer Ingelheim
Colorcon
AstraZeneca
Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

CORTEF Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Cortef, and what generic alternatives are available?

Cortef is a drug marketed by Pharmacia And Upjohn and is included in five NDAs.

The generic ingredient in CORTEF is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrocortisone acetate profile page.

Drug patent expirations by year for CORTEF
Drug Prices for CORTEF

See drug prices for CORTEF

Recent Clinical Trials for CORTEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityEarly Phase 1
National Cancer Institute (NCI)Phase 1
Medical Matters International Ltd.Phase 1

See all CORTEF clinical trials

Pharmacology for CORTEF

US Patents and Regulatory Information for CORTEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORTEF hydrocortisone INJECTABLE;INJECTION 009864-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTEF ACETATE hydrocortisone acetate OINTMENT;TOPICAL 008917-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTEF hydrocortisone TABLET;ORAL 008697-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTEF ACETATE hydrocortisone acetate OINTMENT;TOPICAL 008917-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTEF hydrocortisone cypionate SUSPENSION;ORAL 009900-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
McKesson
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.